skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > isogloboside > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycopentaosylceramide > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)

اصطلاح مرجح

alpha-d-galnac-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C53H94N3O29R

والد-عملکردی دارد

جرم

  • 1237.318

جرم تک‌ایزوتوپی

  • 1236.59730

اسمایلٓ

  • O([C@@H]1[C@H](O[C@@H](OC[C@@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)NC(=O)*)[C@@H]([C@H]1O)O)CO)[C@@H]2O[C@@H]([C@@H]([C@@H]([C@H]2O)O[C@H]3O[C@@H]([C@@H]([C@@H]([C@H]3O)O[C@H]4[C@@H]([C@H]([C@H]([C@@H](CO)O4)O)O[C@@H]5[C@@H]([C@H]([C@H]([C@@H](CO)O5)O)O)NC(C)=O)NC(C)=O)O)CO)O)CO

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • iForssman(t18:0)
  • iso-Forssman(t18:0)
  • isogloboside i-Forssman (t18:0)
  • N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
  • N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-(4R)-hydroxysphinganine

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141044

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD